ClearPoint Neuro, Inc. CLPT
Updated: 10 Aug 2026
No signal published yet
We already track ClearPoint Neuro and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.
Email when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Temporary check — not Firelda's published signal.
General analysis — not personal advice.
Want to follow ClearPoint Neuro, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow ClearPoint Neuro free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Recent News
On August 3, 2026, ClearPoint Neuro reported its second-quarter 2026 financial results, with total revenue increasing 18% year-over-year to $10.9 million. The company adjusted its full-year 2026 revenue guidance to $48 million to $52 million as it prioritizes investments in its preclinical facility and clinical support capacity. Cash and cash equivalents stood at $29.4 million as of June 30, 2026.
What Firelda Watch includes for ClearPoint Neuro, Inc.
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — a short weekly roundup
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Want to follow ClearPoint Neuro, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow ClearPoint Neuro free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more